Skip to main content
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2004 Mar;81(1):118–121. doi: 10.1093/jurban/jth093

Public funding of US Syringe Exchange Programs

Don C Des Jarlais 1,, Courtney McKnight 1, Judith Milliken 1
PMCID: PMC3456139  PMID: 15047790

Abstract

Although there has been no federal government funding of syringe exchange, there is substantial state and local government funding. We report here on program characteristics associated with receiving state and local government funding. Annual telephone surveys were made of program directors of syringe exchange programs known to the North American Syringe Exchange Network. The number of syringe exchange programs known to this network has increased from 63 in 1994–1995 to 127 in 2000. Approximately 80% of programs participated in each of the surveys. Approximately 50% of programs receive state and local government funding, and this has remained constant from 1994 to 2000. Receiving state and local government funding was associated with larger numbers of syringes exchanged per year and providing more on-site services. Among programs that received state or local government funding, this funding accounted for a mean of 87% of the budget for syringe exchange services. In the absence of federal funding, state and local government support is associated with better syringe exchange performance.

Keywords: Syringe exchange programs, State or local government funding, North American Syringe Exchange Network

Full Text

The Full Text of this article is available as a PDF (52.0 KB).

References

  • 1.Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991. doi: 10.1016/S0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
  • 2.Jarlais DC, Hagan HH, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274:1226–1231. doi: 10.1001/jama.274.15.1226. [DOI] [PubMed] [Google Scholar]
  • 3.Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injecting drug users participating in the Tacoma syringe exchange program. Am J Public Health. 1995;85:1531–1537. doi: 10.2105/AJPH.85.11.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.MacDonald M, Wodak AD, Ali R, et al. HIV prevalence and risk behavior in needle exchange attenders: a national study. Med J Aust. 1997;166:237–240. [PubMed] [Google Scholar]
  • 5.Normand J, Vlahov D, Moses LE, editors. Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy Press/National Research Council/ Institute of Medicine; 1995. [PubMed] [Google Scholar]
  • 6.Strathdee SA, Vlahov D. The effectiveness of needle exchange programs: a review of the science and policy. AID Science. 2001;1.
  • 7.Strathdee S, Patrick D, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injection drug use study. AIDS. 1997;11:F59–F65. doi: 10.1097/00002030-199708000-00001. [DOI] [PubMed] [Google Scholar]
  • 8.Lee LM, McKenna M, National Center for HIV S, and TB Prevention, Sharpe TT, EIS Officer C HIV diagnosis among injection-drug users in states with HIV surveillance—25 states, 1994–2000. MMWR Morb Mortal Wkly Rep. 2003;52:634–636. [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES